ReviewMovement disorders clinical practice2014
The Clinical Spectrum of Autosomal-Dominant Episodic Ataxias.
Review in Movement disorders clinical practice, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
13 citing papers in PubMed.
- Huntington's Disease-like Syndrome as a Rare Presentation of CACNA1A-Related Disorder.Movement disorders clinical practice · 2026Article
- Dissociable effects of medication on visual-vestibular brain excitability by visual motion stimuli in episodic ataxia type 2.Brain communications · 2025Article
- [Episodic ataxia type 2: a clinical, genetic and radiological study of 10 patients].Revista de neurologia · 2023Article
- Evaluation of Cerebellar Ataxic Patients.Neurologic clinics · 2023Review
- CACNA1A-Related Channelopathies: Clinical Manifestations and Treatment Options.Handbook of experimental pharmacology · 2023Review
- Clinical features andZhong nan da xue xue bao. Yi xue ban = Journal of Central South University. Medical sciences · 2022Article
- A NovelJournal of clinical neurology (Seoul, Korea) · 2021Article
- Paroxysmal Movement Disorders.Frontiers in neurology · 2021Review
- A novel pathogenic CACNA1A variant causing episodic ataxia type 2 (EA2) spectrum phenotype in four family members and a novel combined therapy.Journal of neurology · 2020Article
- Involvement of the Peripheral Nervous System in Episodic Ataxias.Biomedicines · 2020Review
- Episodic Ataxias: Faux or Real?International journal of molecular sciences · 2020Review
- A Novel CACNA1A Nonsense Variant [c.4054C>T (p.Arg1352Case reports in neurological medicine · 2018Article
- Case report of novelSAGE open medical case reports · 2017Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Autosomal-dominant episodic ataxias (EAs) represent a clinically and genetically heterogeneous group of disorders characterized by recurrent episodes of cerebellar ataxia (CA). Ataxia episodes are usually of short duration and often triggered by specific stimuli. There are currently seven classified subtypes of EA. EA types 1 and 2 have the highest prevalence and are therefore the clinically most relevant. Between attacks, EA 1 is associated with myokymia. In EA 2, often an interictal downbeat nystagmus with other cerebellar ocular dysfunctions is present; patients with EA 2 may display slowly progessive ataxia and vermian atrophy. EA 1 and 2 are both channelopathies, affecting the potassium channel gene,
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.